Although great progress has been made in the treatment and care of breast cancer patients, there is still more work to be done. Our Global Medical Grant programs support independent research, quality improvement, and education initiatives that fill evidence gaps, improve quality of care, and provide independent medical and patient education initiatives around the world. Pfizer has awarded nearly $200M in global medical grants for breast cancer to date.
These grants, administered through Conquer Cancer’s EveryGrant® solution, are part of the Pfizer Global Medical Grants Program Equitable Care of Metastatic Breast Cancer (mBC) Patients: A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color.
Grant recipients are currently conducting a deep, data-based analysis of inequities within their own systems across a myriad of variables, including but not limited to socioeconomic determinants of access to care and point-of-care entry, age, financial barriers to care, and inequities in rural vs urban healthcare delivery.
Learn more about the grant recipients and the work they are undertaking.
Maysa Abu-Khalaf, MD
Thomas Jefferson University
The impact of social determinants of health on cancer care delivery and outcomes of metastatic breast cancer patients
Julie Bradley, MD
University of Florida
Unveiling Inequities in Palliative and Supportive Care for Metastatic Breast Cancer Patients in the State of Florida
Carolyn Brown, PhD
The University of Texas at Austin
Assessing Equity of Care Across Metastatic Breast Cancer Treatment Junctures: A Data-Driven Vulnerability Cluster Approach
Generosa Grana, MD
MD Anderson Cancer Center at Cooper
Assessment of Equitable Care for Black and Women of Color with mBC
Katherine Reeder-Hayes, MD
University of North Carolina Lineberger Comprehensive Cancer Center
Impact of Social Determinants on Treatment Access and Outcomes of Metastatic Breast Cancer Among Black Women
Shoshana Rosenberg, ScD, MPH
Weill Cornell Medicine
Identifying unmet needs and barriers to receipt of psychosocial care in men and women with metastatic breast cancer from diverse racial and ethnic backgrounds treated in an urban hospital network
During the 2022 San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer research conference, Conquer Cancer and Pfizer brought these six investigators together for an Investigator Exchange. The investigators shared the findings and lessons learned from their analyses of inequities within their health-care systems, and engaged in a productive discussion about solutions needed to achieve equity and improve outcomes for underserved mBC patients.
Conquer Cancer®, the ASCO Foundation, funds research for every cancer, every patient, everywhere. Since 1984, its Grants & Awards program has awarded more than $158 million through more than 2,600 grants and awards to improve cancer care and accelerate breakthroughs in clinical and translational oncology research. Conquer Cancer’s EveryGrant® program is an end-to-end, white label solution, helping organizations develop and deliver grants programs that attract the brightest researchers and make a difference for people with cancer everywhere. For more information, visit CONQUER.ORG.